Lymphopenia, hyper-inflammatory state, and cytokines all appear to play a role in COVID-19 pathology; therefore, the hypothesis has been proposed that immunomodulatory drugs may be useful for reversing and treating the disease.
Although COVID-19 has many manifestations, lung injury and severe acute respiratory failure (SRF) are more common.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
